Literature DB >> 975821

Pharmacokinetic observations on medroxyprogesterone acetate administered orally and intravaginally.

A Victor, E D Johansson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 975821     DOI: 10.1016/0010-7824(76)90099-8

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  7 in total

Review 1.  Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception.

Authors:  Frank Z Stanczyk
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

Review 2.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 3.  Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

Authors:  Frank Z Stanczyk; Janet P Hapgood; Sharon Winer; Daniel R Mishell
Journal:  Endocr Rev       Date:  2012-12-13       Impact factor: 19.871

4.  Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routes.

Authors:  M Salimtschik; H T Mouridsen; J Loeber; E Johansson
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

5.  Medroxyprogesterone acetate bioavailability after high-dose intraperitoneal administration in advanced cancer.

Authors:  C M Camaggi; E Strocchi; B Costanti; P Beghelli; P Ferrari; F Pannuti
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 6.  Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.

Authors:  Alexis J Bick; Renate Louw-du Toit; Salndave B Skosana; Donita Africander; Janet P Hapgood
Journal:  Pharmacol Ther       Date:  2020-12-13       Impact factor: 13.400

7.  Thermosensitive progesterone hydrogel: a safe and effective new formulation for vaginal application.

Authors:  Aliyah Almomen; Sungpil Cho; Chieh-Hsiang Yang; Zhengzheng Li; Elke A Jarboe; C Matthew Peterson; Kang Moo Huh; Margit M Janát-Amsbury
Journal:  Pharm Res       Date:  2015-01-22       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.